Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,220,325
+$271,445 QoQ
Shares Held
32,843
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,117
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. MRK ranks #4 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,220,325 | 32,843 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,948,880 | 32,828 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,008,436 | 28,581 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,911,589 | 22,776 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,724,658 | 21,787 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,800,047 | 20,054 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,208,853 | 22,204 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,111,998 | 27,404 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $5,241,196 | 42,336 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,544,753 | 34,443 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,674,696 | 24,534 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,316,534 | 32,215 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,216,350 | 36,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,694,858 | 25,330 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,050,237 | 27,492 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,409,637 | 27,980 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,630,710 | 28,855 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,146,838 | 26,165 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,959,301 | 25,565 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,915,305 | 25,500 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,983,135 | 25,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,042,886 | 26,500 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,413,098 | 29,500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,529,976 | 30,500 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,358,566 | 30,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,115,849 | 27,500 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||